Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112824422B discloses a novel chiral ligand enabling high TON asymmetric hydrogenation for pharma intermediates with simplified synthesis.
Novel synthesis route for TL214 impurity ensures high purity and supply stability for DPP-4 inhibitor quality control processes globally. This method offers significant cost reduction in pharmaceutical intermediates manufacturing while maintaining stringent quality standards for regulatory compliance.
Novel 3-step route for bilastine intermediate via Pd-catalysis. High yield, mild conditions, cost-effective manufacturing for global supply chains.
Patent CN117402085B reveals a novel route for Sacubitril intermediates. Achieve high purity and cost reduction in API manufacturing with scalable processes.
Novel Friedel-Crafts route for Canagliflozin intermediate. High purity, scalable process reducing raw material complexity for global supply chains.
Patent CN117385378B reveals green electrooxidation for aromatic aldehydes. Enhance supply chain reliability and reduce manufacturing costs with scalable synthesis.
Patent CN102603652A reveals a mild three-step synthesis for 5-formylpyrimidine carbocyclic nucleosides, offering a reliable route for antiviral intermediate manufacturing.
Patent CN119332255B reveals metal-free electrochemical route. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Advanced preparation method for Telmisartan intermediates featuring high yield, mild conditions, and avoidance of toxic cyanide. Ideal for scalable pharmaceutical manufacturing.
Patent CN102219779A details a high-yield Irbesartan synthesis avoiding toxic tin reagents. Discover cost-effective manufacturing and supply chain advantages.
Patent CN113200997B details scalable route for high-purity pharmaceutical intermediates with cost-effective raw materials and simplified purification steps.
Novel Ullmann coupling method for high-purity chiral ligands. Reduces steps and improves yield for asymmetric catalysis applications.
Patent CN111718253B reveals a high-yield route for rhodium caprylate dimer, offering cost-effective homogeneous catalysis solutions for pharmaceutical intermediates.
Patent CN107973747A details a high-yield chlorination process enhancing supply chain stability and reducing manufacturing costs for global pharmaceutical intermediate procurement.
Patent CN103193753B reveals acidic ionic liquid catalysis for xanthene dione derivatives, offering high yield and recyclability for pharmaceutical intermediate supply chains.
Patent CN108358913A offers green synthesis for Rotundine Sulfate. Reduces cost and improves yield for pharmaceutical intermediates supply chain.
Novel gold-catalyzed route for aryl indole intermediates ensures high yield and scalable production for global pharmaceutical supply chains and cost efficiency.
Patent CN107098950B reveals a novel liquid-phase synthesis for GHK tripeptides offering superior purity and cost efficiency for global supply chains.
Novel copper-catalyzed decarboxylative acylation method offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN103820416B reveals high-stereoselectivity ester hydrolase for chiral synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.